术前阿片类药物使用是否增加早期全髋关节置换翻修风险
该研究利用Humana数据库分析2007至2015年间17695例单侧初次全髋关节置换患者,随访2年,发现术前3个月内使用阿片类药物者早期翻修风险显著升高(1.2% vs 0.7%,P < .001),肥胖和焦虑/抑郁也是独立预测因素。作者认为这些因素应纳入风险校正模型,并需进一步研究术前停用阿片类药物能否降低该风险。
要点
- 术前3个月内使用阿片类药物与早期全髋翻修风险独立相关(1.2% vs 0.7%,P < .001)。
- 肥胖(1.3% vs 0.8%,P = .03)和焦虑/抑郁(1.9% vs 0.8%,P = .006)也显著增加早期翻修风险。
- 作者建议在质量评估或捆绑支付的风险校正模型中考虑这些因素。
核心结论
- 术前3个月内使用阿片类药物独立预测全髋关节置换术后早期翻修风险增加。
- 肥胖和焦虑/抑郁诊断也是早期翻修的独立预测因素。
- 作者认为这些因素需在风险校正模型中考虑,并需进一步研究术前停用阿片类药物能否降低该风险。
研究设计与样本
- 回顾性数据库分析,查询Humana数据库2007至2015年间单侧初次全髋关节置换患者,随访2年,采用多变量逻辑回归分析计算比值比。
主要发现
- 共分析17695例初次全髋关节置换患者,0.88%(n = 155)在2年内接受翻修。
- 术前阿片类药物使用见于36.7%的患者,女性占58.7%,80%年龄>50岁。
- 术前阿片类药物使用者早期翻修率显著更高(1.2% vs 0.7%,P < .001)。
- 肥胖患者早期翻修率显著更高(1.3% vs 0.8%,P = .03)。
- 术前诊断焦虑/抑郁者早期翻修率显著更高(1.9% vs 0.8%,P = .006)。
临床怎么用
- 作者认为术前3个月内使用阿片类药物、肥胖和焦虑/抑郁等因素应在评估医疗质量或实施捆绑支付时纳入风险校正模型。
- 作者指出需进一步研究术前停用阿片类药物是否能减轻早期翻修风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to evaluate the impact of preoperative opioid use on the risk of subsequent revison after primary total hip arthroplasty (THA). METHODS: The Humana database was queried for unilateral THA between 2007-2015. Patients were tracked for the occurrence of an ipsilateral revision THA for 2 years. Factors analyzed included preoperative opioid use (defined as a history of opioid prescription filled within 3 months preceding primary THA), age, sex, diabetes, anxiety/depression, chronic kidney disease, and obesity (body mass index > 30 kg/m2). Multivariate logistic regression analysis was used to determine odds ratios. RESULTS: A total of 17,695 primary THA patients were analyzed and 0.88% (n = 155) underwent revision THA within 2 years. Preoperative opioid use occurred in 36.7% of all. Females comprised 58.7% of the total cohort and 80% were >50 years. Preoperative opioid users were significantly more likely to undergo early THA revision (1.2% vs 0.7%, P < .001). Other patient factors that significantly increased the risk of early THA revision included obesity (1.3% vs 0.8%, P = .03) and a preoperative diagnosis of anxiety/depression (1.9% vs 0.8%, P = .006). CONCLUSION: Opioid use within 3 months preceding THA independently predicts an increased risk of early revision. Additionally, independent predictors of early revision include obesity and a diagnosis of anxiety/depression. Factors such as these will need to be considered in risk adjustment models when assessing quality of care or implementing bundled payment initiatives. Further research is needed to evaluate whether discontinuing opioids before surgery mitigates this risk.
引用
- Bedard NA, DeMik DE, Dowdle SB, et al. Does Preoperative Opioid Use Increase the Risk of Early Revision Total Hip Arthroplasty? J Arthroplasty. 2018. PMID: 29452972. doi:10.1016/j.arth.2018.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。